Wolverine World Wide CEO Executes Options, Retains 231,558 Shares
Rhea-AI Filing Summary
Wolverine World Wide, Inc. (WWW) reporting person Christopher Hufnagel, President and CEO, executed option exercises and share transactions on 08/28/2025. He exercised stock options with a $16.51 exercise price to acquire 32,294 shares and immediately reported a sale of 32,294 shares at a weighted-average price of $31.91, leaving him with 231,558 shares beneficially owned after the transactions. The exercised option had staggered vesting dates beginning in 2017 and expires 02/09/2026. The filer notes the sale prices ranged from $31.72 to $32.17 and offers to provide per-price breakdowns on request.
Positive
- Transparency of pricing: Filing discloses weighted-average sale price and offers per-trade breakdown on request
- Substantial retained ownership: Reporting person still beneficially owns 231,558 shares after the transactions
Negative
- Immediate sale of all exercised shares indicates no incremental share retention from this exercise
- Limited execution detail: Only weighted-average sale price is provided, lacking per-trade quantities without a request
Insights
TL;DR CEO exercised vested options and sold the same number of shares, reducing direct holdings while retaining significant ownership.
The report documents a routine insider exercise-and-sale transaction by the CEO executed on 08/28/2025. Exercising options at a $16.51 strike and selling at a weighted-average $31.91 produced a realized spread that is explicit in the filing. The remaining beneficial ownership of 231,558 shares indicates continued significant alignment with shareholders despite the sale. The filing discloses weighted-average sale pricing only and commits to provide a per-trade breakdown if requested, which limits immediate granularity on execution timing within the day.
TL;DR Transaction is a standard, permissible Section 16 disclosure showing option exercise and contemporaneous sale by an officer.
The Form 4 shows the reporting person is both an officer and a director, and the disclosure follows Section 16 reporting conventions. The option exercised was partially vested across prior years with an expiration in February 2026, confirming lawful exercise. The contemporaneous sale of all acquired shares suggests this was not a retention transaction; however, the report does not indicate a 10b5-1 plan box checked, so sale timing context is limited to the filing. Material corporate governance implications appear minimal given continued large share ownership.